These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 580902)
1. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells. LePage GA Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin. LePage GA; Worth LS; Kimball AP Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. White EL; Shaddix SC; Brockman RW; Bennett LL Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080 [TBL] [Abstract][Full Text] [Related]
4. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells. Cass CE; Selner M; Phillips JR Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Ono K; Ohashi A; Yamamoto A; Matsukage A; Takahasi T; Saneyoshi M; Ueda T Cancer Res; 1979 Nov; 39(11):4673-80. PubMed ID: 91427 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin. Cass CE; Au-Yeung TH Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095 [TBL] [Abstract][Full Text] [Related]
7. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. Brockman RW; Cheng YC; Schabel FM; Montgomery JA Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636 [TBL] [Abstract][Full Text] [Related]
8. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Müller WE; Rohde HJ; Beyer R; Maidhof A; Lachmann M; Taschner H; Kahn RK Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031 [TBL] [Abstract][Full Text] [Related]
9. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase. Helland S; Ueland PM Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909 [TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine. Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709 [TBL] [Abstract][Full Text] [Related]
11. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo. Müller WE; Maidhof A; Zahn RK; Shannon WM Cancer Res; 1977 Jul; 37(7 Pt 1):2282-90. PubMed ID: 301056 [No Abstract] [Full Text] [Related]
12. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM; Rustum YM Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [TBL] [Abstract][Full Text] [Related]
13. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity. Fridland A Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707 [TBL] [Abstract][Full Text] [Related]
14. Unusual sensitivity to bleomycin and joint resistance to 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine of mouse FM3A cell mutants with altered ribonucleotide reductase and thymidylate synthase. Ayusawa D; Iwata K; Seno T Cancer Res; 1983 Feb; 43(2):814-8. PubMed ID: 6184158 [TBL] [Abstract][Full Text] [Related]
15. Correlation of cytotoxicity with total intracellular exposure to 9-beta-D-arabinofuranosyladenine 5'-triphosphate. Shewach DS; Plunkett W Cancer Res; 1982 Sep; 42(9):3637-41. PubMed ID: 6179604 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388. Avramis VI; Plunkett W Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151 [TBL] [Abstract][Full Text] [Related]
17. Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells. Shewach DS; Plunkett W Cancer Res; 1986 Apr; 46(4 Pt 1):1581-4. PubMed ID: 2418951 [TBL] [Abstract][Full Text] [Related]
18. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine. Kufe D; Herrick D; Crumpacker C; Schnipper L Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173 [TBL] [Abstract][Full Text] [Related]
19. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity. Kufe DW; Major PP; Munroe D; Egan M; Herrick D Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429 [TBL] [Abstract][Full Text] [Related]
20. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells. Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]